CD4 and neoplasm: In tumor models of melanoma and fibrosarcoma, myeloid-specific SHP-2 ablation led to increased tumor infiltration by proinflammatory monocytes and concomitant recruitment and activation of CD4+ and CD8+ TEF cells.